4//SEC Filing
Avista Capital Managing Member IV, LLC 4
Accession 0001140361-20-026482
CIK 0001661181other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 6:10 PM ET
Size
66.7 KB
Accession
0001140361-20-026482
Insider Transaction Report
Form 4
Avista Acquisition Corp.
10% Owner
Transactions
- Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes)
Transactions
- Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes)
Avista Capital Partners IV GP, L.P.
10% Owner
Transactions
- Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes)
Dean Thompson
DirectorExecutive Chairman10% Owner
Transactions
- Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes)
Avista Acquisition, LLC
10% Owner
Transactions
- Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes)
Avista Capital Partners IV, L.P.
10% Owner
Transactions
- Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes)
Transactions
- Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes)
Burgstahler David F
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Class A common stock
2020-11-20$4.99/sh+2,739$13,671→ 29,924,415 total(indirect: See Notes) - Purchase
Class A common stock
2020-11-24$5.00/sh+100$500→ 29,924,515 total(indirect: See Notes)
Footnotes (7)
- [F1]This statement is being filed by the following Reporting Persons: Avista Acquisition Corp. (the "Sponsor"); Avista Acquisition LLC, which is the sole shareholder of the Sponsor; Avista Capital Partners IV, L.P. ("ACP Onshore"); Avista Capital Partners (Offshore) IV, L.P. ("ACP Offshore"); Avista Capital Partners IV GP, L.P. ("Avista GP"), which is the general partner of ACP Onshore and ACP Offshore; Avista Capital Managing Member IV, LLC, which is the general partner of Avista GP; Thompson Dean; and David Burgstahler.
- [F2]The number of securities reported represents an aggregate number of shares of Class A common stock of the Issuer ("Common Stock") purchased in multiple market transactions over a range of purchase prices. The price reported represents the weighted average price per share. Each Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, the Issuer, or a stockholder of the Issuer, upon request, the number of shares of Common Stock purchased by the Reporting Person at each separate price within the range.
- [F3]Represents an aggregate of 1,373 shares of Common Stock purchased by ACP Onshore and 1,366 shares of Common Stock purchased by ACP Offshore.
- [F4]Purchase prices range from $4.98 to $5.00 per share, inclusive.
- [F5]Represents an aggregate of 50 shares of Common Stock purchased by ACP Onshore and 50 shares of Common Stock purchased by ACP Offshore.
- [F6]Because of the relationship among the Reporting Persons, the Reporting Persons may be deemed to beneficially own the securities reported herein to the extent of their respective pecuniary interests. Each Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any. Joshua Tamaroff, an employee of an affiliate of the Reporting Persons, serves on the board of directors of the Issuer as a representative of the Reporting Persons.
- [F7]Pursuant to Rule 16a-1(a)(4) under the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owners of any equity securities in excess of their respective pecuniary interests
Issuer
Organogenesis Holdings Inc.
CIK 0001661181
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001761175
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 6:10 PM ET
- Size
- 66.7 KB